Replies to post #1869 on Momenta Pharmaceuticals, Inc. (MNTA)

[10nisman]

Let's hope that something happens soon because before we know it Momenta will run through its tax credits and the street will have to factor in income taxes.

Income taxes are not an issue. Assuming a $225M per quarter mL run-rate, MNTA will not burn through its NOL's until sometime in Q1 2012. Also, most analysts covering MNTA do not have mL maintaining sole generic status past Q2 2011. Therefore analysts will likely have to raise their estimates come this summer.

I have MNTA earning after tax profits of approximately $2/share in 2012 under a sole generic situation. Based on that estimate MNTA is currently trading at a forward PE of 5 (net of cash and AR) and a forward PE of 4 (net of cash, AR and NOL's).

[Mpower]

I have a old friend on this board, who shall remain anonymous.... i advised him about 2 years ago that TEVA HQ in Jerusalem would not let MNTA "walk all over them". TEVA HQ is adept at crushing and vexing its competition -- those who expect mC to be the end-game, don't really understand the significance of MNTA's stock price cratering from 26-->12 after mL approval. The only hope MNTA has at this point ... is becoming acquired (which i feel is very likely over the next few months). TEVA has a lot of friends at this game and they will make sure MNTA (and its investors) don't get a leg up (even though they have won "fair in square"). Good luck MNTA longs... but you are swimming against a big tide, and better hope you are scooped up by the NVS yacht.